GlassScriptPhysician profile
Azizul Rehman
NPI 1407275290
$3,291.95
in general payments reported to CMS, 2019-2025
26 companies · $919 in 2025
The $919 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $198 · 2021: $780 · 2022: $289 · 2023: $145 · 2024: $536 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,600.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $399.94 | 2019-2020 | |
| Boston Scientific Corporation | $381.56 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $365.72 | 2021-2025 | |
| Heartflow, INC. | $312.83 | 2024-2025 | |
| Medtronic, INC. | $279.05 | 2021-2024 | Corevalve Evolut R |
| Cleerly, INC. | $262.20 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Biotronik INC. | $213.00 | 2021-2024 | Biomonitor |
| Pfizer INC. | $198.63 | 2022-2025 | |
| Abbott Laboratories | $117.58 | 2022-2025 | Jot Dx, Ensite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.51 | 2022-2024 | Lifevest |
| Itamar Medical INC | $101.56 | 2022 | |
| Arineta, INC | $83.40 | 2024 | Spotlight |
| Novartis Pharmaceuticals Corporation | $77.28 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $75.23 | 2024-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.81 | 2025 | Jardiance |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $32.48 | 2024 | |
| Baxter Healthcare | $32.14 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Otsuka America Pharmaceutical, INC. | $28.43 | 2023 | Rexulti |
| Biosense Webster, INC. | $23.45 | 2024 | Carto 3 |
| Vital Connect, INC | $22.07 | 2025 | Vitalpatch Rtm |
| Angiodynamics, INC. | $20.66 | 2023 | Auryon Laser System 100-120 Vac |
| Alnylam Pharmaceuticals INC. | $19.05 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $18.00 | 2022 | |
| Becton, Dickinson and Company | $16.92 | 2025 | Lutonix Drug Coated Balloon |
| Irhythm Technologies, INC. | $16.74 | 2024 | Zio Monitor, Zio Xt Patch |
| Amgen INC. | $16.71 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azizul Rehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.